Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 30, 2009

Premium

Heiner Dreismann, former CEO of Roche Molecular Diagnostics, has joined the board of directors at Shrink Nanotechnologies, and he will chair the company's business advisory board. Before he served as CEO at Roche, Dreismann was a senior executive in the company's business unit for PCR and microbiology.


Luminex last week made three senior appointments. Michael Pintek has been named senior vice president of operations; Jeremy Bridge-Cook has been named senior vice president of the firm's assay group; and Nancy Krunic has been named vice president of Luminex Molecular Diagnostics.

Pintek joins Luminex from Roche, where he was most recently vice president and general manager of blood screening for Roche Molecular Systems. He has also held positions at Ventana Medical Systems and Abbott Laboratories.
Bridge-Cook was vice president of Luminex Molecular Diagnostics since Luminex acquired Tm Bioscience in 2007. He had been with Tm since 2001.

Krunic was associate vice president of clinical and regulatory affairs at Luminex Molecular Diagnostics. Prior to that, she held a variety of positions at Tm.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.